JP Morgan Chase’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.23K Hold
756
﹤0.01% 7095
2025
Q4
$1.69K Hold
756
﹤0.01% 6968
2025
Q3
$1.83K Sell
756
-1,667,886
-100% -$4.44M ﹤0.01% 6932
2025
Q2
$988K Buy
1,668,642
+1,615,243
+3,025% +$1.26M ﹤0.01% 4387
2025
Q1
$46.8K Sell
53,399
-13,016
-20% -$18.1K ﹤0.01% 5905
2024
Q4
$112K Buy
66,415
+19,585
+42% +$35.3K ﹤0.01% 5709
2024
Q3
$89.9K Buy
46,830
+18,472
+65% +$41.9K ﹤0.01% 5744
2024
Q2
$69.8K Buy
28,358
+7,546
+36% +$20.3K ﹤0.01% 5712
2024
Q1
$34.1K Sell
20,812
-9,252
-31% -$13.6K ﹤0.01% 6075
2023
Q4
$53.5K Buy
30,064
+133
+0.4% +$285 ﹤0.01% 5976
2023
Q3
$137K Sell
29,931
-18,076
-38% -$173K ﹤0.01% 5298
2023
Q2
$537K Buy
48,007
+43,725
+1,021% +$465K ﹤0.01% 4440
2023
Q1
$49K Buy
4,282
+915
+27% +$9.74K ﹤0.01% 5708
2022
Q4
$23K Buy
+3,367
New +$32.2K ﹤0.01% 5844
2022
Q3
Sell
-100,000
Closed -$995K 6769
2022
Q2
$995K Sell
100,000
-310,356
-76% -$3.07M ﹤0.01% 4082
2022
Q1
$4.06M Buy
+410,356
New +$4.05M ﹤0.01% 3181
2021
Q4
Sell
-150,000
Closed -$1.47M 6895
2021
Q3
$1.47M Buy
150,000
+55,300
+58% +$545K ﹤0.01% 4021
2021
Q2
$959K Buy
+94,700
New +$957K ﹤0.01% 4325

Other funds holding PROK

JP Morgan Chase's PROK Position: Q1 2026 in Review

JP Morgan Chase held its ProKidney (PROK) position steady in Q1 2026 at 756 shares worth $1.23K. The position accounts for ﹤0.01% of the portfolio, ranked #7095.

JP Morgan Chase first reported a position in PROK in Q2 2021 and has held it in 18 quarters since. The position peaked at $4.06M in Q1 2022. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • JP Morgan Chase held 756 shares of ProKidney worth $1.23K as of Q1 2026.
  • JP Morgan Chase left its ProKidney share count unchanged in Q1 2026.
  • ProKidney made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7095 holding.
  • JP Morgan Chase first reported a position in ProKidney in Q2 2021 and has held it in 18 quarters since.
  • JP Morgan Chase's ProKidney position peaked at $4.06M in Q1 2022.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.